La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Innospec a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Innospec..

Innospec (NASDAQ:IOSP) Azioni, Catena delle Opzioni

Innospec

Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The fuel specialties segment, which generates the majority of revenue, sells products used to improve fuel efficiency, boost engine performance, and reduce emissions for automobiles, boats, and airplanes. It also sells products used by oil field services providers in the extraction of oil and gas. The performance chemicals segment sells products to the personal-care industry. The Oilfield Services segment develops and markets products to prevent loss of mud.

Innospec Inc

Cash generation was excellent. With over $300 million in net cash we expect to continue to pursue organic investments and complementary M&amp;A while returning value to shareholders through dividend growth. In line with this, I am pleased to announce an increase in our semi-annual dividend to 79 cents, bringing our dividend to $1.55 for the full year, an annual increase of 10 percent.&quot;

News

Dividends

IOSP

CORRECTION: Innospec Increases Semi-Annual Dividend To $0.79, Bringing Dividend To $1.55 For The Full Year

Innospec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOSP#NASDAQ">IOSP</a>) reported quarterly earnings of $1.35 per share which met the analyst consensus estimate. This is a 15.09 percent decrease over earnings of $1.59 per share from the same period last year. The company reported quarterly sales of $443.40 million which beat the analyst consensus estimate of $442.13 million by 0.29 percent. This is a 4.46 percent decrease over sales of $464.10 million the same period last year.

Earnings

Earnings Beats

Innospec Q3 2024 Adj EPS $1.35, Inline, Sales $443.40M Beat $442.13M Estimate

On August 27, a recent SEC filing unveiled that Ian Cleminson, VP &amp; CFO at Innospec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOSP#NASDAQ">IOSP</a>) made an insider sell.
What Happened: According to a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001054905/000095017024101138//Archives/edgar/data/1054905/000095017024101138/0000950170-24-101138-index.htm">U.S. Securities and Exchange Commission</a> on Tuesday, Cleminson sold 10,000 shares of Innospec. The total transaction value is $1,139,889.
The latest update on Wednesday morning shows Innospec shares down by 0.0%, trading at $113.89.
<h3>Discovering Innospec: A Closer Look</h3>
Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The fuel specialties segment, which generates the majority of revenue, sells products used to improve fuel efficiency, boost engine performance, and reduce emissions for automobiles, boats, and airplanes. It also sells products used by oil field services providers in the extraction of oil and gas. The performance chemicals segment sells products to the personal-care industry. The Oilfield Services segment develops and markets products to prevent loss of mud.
<h3>Unraveling the Financial Story of Innospec</h3>
Decline in Revenue: Over the 3 months period, Innospec faced challenges, resulting in a decline of approximately -9.45% in revenue growth as of 30 June, 2024. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.
Profitability Metrics:
<ul>
<li>
Gross Margin: The company faces challenges with a low gross margin of 29.17%, suggesting potential difficulties in cost control and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Innospec's EPS is below the industry average. The company faced challenges with a current EPS of 1.25. This suggests a potential decline in earnings.
</li>
</ul>
Debt Management: Innospec's debt-to-equity ratio is below the industry average at 0.04, reflecting a lower dependency on debt financing and a more conservative financial approach.
Analyzing Market Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: The current P/E ratio of 19.08 is below industry norms, indicating potential undervaluation and presenting an investment opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 1.51 is below industry norms, suggesting potential undervaluation and presenting an investment opportunity for those considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Innospec's EV/EBITDA ratio at 12.02 suggests potential undervaluation, falling below industry averages.
</li>
</ul>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Navigating the Impact of Insider Transactions on Investments</h3>
It's important to note that insider transactions alone should not dictate investment decisions, but they can provide valuable insights.
In the context of legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as outlined by Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are obligated to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.
Despite insider sells not always signaling a bearish sentiment, they can be driven by various factors.
<h3>Unlocking the Meaning of Transaction Codes</h3>
Taking a closer look at transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often prioritize those unfolding in the open market, meticulously cataloged in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C denotes the conversion of an option, and transaction code A signifies a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001054905">Check Out The Full List Of Innospec's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Trading Ideas

Ian Cleminson Implements A Sell Strategy: Offloads $1.14M In Innospec Stock

WIIM

Innospec shares are trading lower after the company reported worse-than-expected Q2 sales results.

Innospec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOSP#NASDAQ">IOSP</a>) reported quarterly earnings of $1.39 per share which beat the analyst consensus estimate of $1.37 by 1.46 percent. The company reported quarterly sales of $435.000 million which missed the analyst consensus estimate of $480.400 million by 9.45 percent. This is a 9.45 percent decrease over sales of $480.400 million the same period last year.

Earnings Misses

Innospec Q2 2024 Adj. EPS $1.39 Beats $1.37 Estimate, Sales $435.000M Miss $480.400M Estimate

PPG Industries, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ppg#NYSE">PPG</a>) reported a second-quarter 2024 profit of $528 million or $2.24 per share, up from $490 million or $2.06 per share in the year-ago quarter.
In the second quarter, excluding one-time items, adjusted earnings per share increased to $2.50 from $2.25 in the year-ago quarter, surpassing the Zacks Consensus Estimate of $2.48.
The company&#39;s revenues were $4,794 million in the quarter, down 1.6% year over year. The top line missed the Zacks Consensus Estimate of $4,913.5 million.
<div class="chart_embed">
<h3>PPG Industries, Inc. Price, Consensus and EPS Surprise</h3>
<h3><img alt="PPG Industries, Inc. Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/d7/1721387769.png" style="height:265px; width:591px" title="" /></h3>
PPG Industries, Inc. price-consensus-eps-surprise-chart | PPG Industries, Inc. Quote
</div>
<h3>Segment Review</h3>
Performance Coatings&#39; second-quarter revenues were $3,048 million. The segment&#39;s net sales were stable, as improved selling prices were offset by the sale of the non-North American portion of the traffic solutions business and adverse foreign currency translation. The figure was below our estimate of $3,101.8 million.
Industrial Coatings generated revenues of $1,746 million, a 4.6% year-over-year decrease. The fall is due to lower selling prices from certain index-based customer contracts and unfavorable foreign currency translation. The figure was below our estimate of $1,831.9 million.
<h3>Financials</h3>
The company had $1.2 billion in cash and short-term investments as of the end of the quarter. Net debt was $5.2 billion, down $0.4 billion from the prior-year quarter.
<h3>Outlook</h3>
The company&#39;s projected adjusted EPS for the third quarter is in the range of $2.10-$2.20. For the full year, the company expects adjusted EPS in the range of $8.15-$8.30. These projections consider various factors such as current global economic activity, uneven global industrial production, reduced global automotive production, stabilizing demand in Europe, sustained growth in Mexico and India and low single-digit growth in China.
<h3>Price Performance</h3>
Shares of PPG have lost 12.1% over the past year compared with 12.8% decline of its industry.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/70/71889.jpg?v=1979758973" /> 
Image Source: Zacks Investment Research
<h3>Zacks Rank &amp; Upcoming Releases</h3>
PPG currently carries a Zacks Rank #4 (Sell).
Some other firms in the basic materials space that are set to release earnings soon are The Scotts Miracle-Gro Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/smg#NYSE">SMG</a>), Ero Copper Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ero#NYSE">ERO</a>) and Innospec Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iosp#NASDAQ">IOSP</a>).
Scotts Miracle-Gro is slated to report fiscal third-quarter results on Jul 31. The Zacks Consensus Estimate for third-quarter earnings is pegged at $1.94 per share. SMG beat the Zacks Consensus Estimate in three of the last four quarters, with the average earnings surprise being 1.44%. SMG carries a Zacks Rank #3 (Hold).
Ero Copper is slated to report second-quarter results on Aug 1, after market close. The Zacks Consensus Estimate for ERO&#39;s second-quarter earnings is pegged at 27 cents. ERO currently carries a Zacks Rank #1.
Innospec is slated to report second-quarter results on Aug 6, after market close. The consensus estimate for Innospec&#39;s second-quarter earnings is pegged at $1.37 per share. IOSP, carrying a Zacks Rank #3, beat the consensus estimate in each of the last four quarters, with the average earnings surprise being 8.22%. The company&#39;s shares have gained around 24.5% in the past year.
<a href="https://www.zacks.com/stock/news/2305079/ppg-industries-ppg-q2-earnings-top-estimates-sales-lag?cid=CS-BENZ-FT-analyst_blog|earnings_article-2305079">To read this article on Zacks.com click here.</a>

Markets

Analyst Ratings

PPG Industries Q2 Earnings Top Estimates, Sales Lag

Innospec's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IOSP#NYSE">IOSP</a>) short percent of float has risen 16.33% since its last report. The company recently reported that it has 201 thousand shares sold short, which is 1.14% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.63 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Innospec Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1718388017_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Innospec has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Innospec's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Innospec's peer group average for short interest as a percentage of float is 3.47%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Innospec?

Innospec' Performance Chemicals Business Enters Into Social Partnership With International Justice Mission

Innospec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOSP#NASDAQ">IOSP</a>) reported quarterly earnings of $1.75 per share which beat the analyst consensus estimate of $1.64 by 6.71 percent. The company reported quarterly sales of $500.200 million which missed the analyst consensus estimate of $504.133 million by 0.78 percent. This is a 1.84 percent decrease over sales of $509.600 million the same period last year.

Innospec Q1 2024 Adj EPS $1.75 Beats $1.64 Estimate, Sales $500.200M Miss $504.133M Estimate

Kronos Worldwide (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kro#NYSE">KRO</a>) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to loss of $0.13 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 75%. A quarter ago, it was expected that this maker of titanium dioxide pigments would post a loss of $0.07 per share when it actually produced a loss of $0.05, delivering a surprise of 28.57%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.
Kronos Worldwide, which belongs to the Zacks Chemical - Diversified industry, posted revenues of $478.8 million for the quarter ended March 2024, surpassing the Zacks Consensus Estimate by 5.31%. This compares to year-ago revenues of $426.3 million. The company has topped consensus revenue estimates just once over the last four quarters.
The sustainability of the stock&#39;s immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management&#39;s commentary on the earnings call.
Kronos Worldwide shares have added about 22.7% since the beginning of the year versus the S&amp;P 500&#39;s gain of 8.8%.
What&#39;s Next for Kronos Worldwide?
While Kronos Worldwide has outperformed the market so far this year, the question that comes to investors&#39; minds is: what&#39;s next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company&#39;s earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Kronos Worldwide: favorable. While the magnitude and direction of estimate revisions could change following the company&#39;s just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future.
It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $0.08 on $496.58 million in revenues for the coming quarter and $0.33 on $2.1 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Chemical - Diversified is currently in the top 34% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, Innospec (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iosp#NASDAQ">IOSP</a>), is yet to report results for the quarter ended March 2024. The results are expected to be released on May 9.
This specialty chemicals company is expected to post quarterly earnings of $1.64 per share in its upcoming report, which represents a year-over-year change of +18.8%. The consensus EPS estimate for the quarter has been revised 1.3% higher over the last 30 days to the current level.
Innospec&#39;s revenues are expected to be $508.15 million, down 0.3% from the year-ago quarter.
<a href="https://www.zacks.com/stock/news/2270989/kronos-worldwide-kro-q1-earnings-and-revenues-beat-estimates?cid=CS-BENZ-FT-tale_of_the_tape|yseop_template_4-2270989">To read this article on Zacks.com click here.</a>

Small Cap

Kronos Worldwide Q1 Earnings and Revenues Beat Estimates

United States Steel Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/x#NYSE">X</a>) said that its shareholders have approved its proposed merger with Nippon Steel Corporation (&quot;NSC&quot;), marking a key milestone toward the completion of the transaction. 
More than 98% of the shares voted at the special meeting of stockholders held on Apr 12, 2024 were voted in favor of the proposal to adopt the merger agreement, based on the preliminary vote count. 
U.S. Steel stated that the overwhelming support from its shareholders is a clear recognition of the compelling rationale for the deal. The transaction will strengthen U.S. Steel and the domestic steel industry and enhance the legacy of steel that is made in America in the wake of unfair competition from China, X noted. 
U.S. Steel and NSC officially entered into a definitive agreement in December 2023, under which, NSC agreed to acquire U.S. Steel in an all-cash deal at $55 per share. The transaction is valued at roughly $14.1 billion-plus assumed debt, equating to a total enterprise value of $14.9 billion. The purchase price of $55 per share represents a substantial 40% premium over U.S. Steel&#39;s closing stock price as of Dec 15, 2023. 
NSC noted that the strategic move to acquire U.S. Steel is aimed at augmenting its global manufacturing and technology capabilities. The acquisition will facilitate an expansion of NSC&#39;s geographical reach, allowing it to better serve stakeholders, including customers and society at large. This strategic expansion will notably increase NSC&#39;s production in the United States, complementing its existing strongholds in Japan, ASEAN and India. 
With the acquisition, NSC&#39;s total annual crude steel capacity is expected to reach 86 million tons, aligning with its strategic objective of achieving 100 million tons of global crude steel capacity annually. NSC also underscored the synergies arising from the transaction, emphasizing the amalgamation of cutting-edge technologies and manufacturing capabilities. 
However, the deal has drawn significant opposition from the Biden administration on concerns about the implications on U.S. national security, supply chains and steel jobs. President Joe Biden, last month, said that U.S. Steel should remain American owned and operated. The U.S. Department of Justice has reportedly launched an extended antitrust investigation into the proposed merger. The United Steelworkers union has also expressed concerns of potential job losses from the transaction. 
U.S. Steel&#39;s shares have rallied 57.4% over the past year, outperforming the 11.3% rise of its industry.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/3d/64986.jpg?v=830857229" /> 
Image Source: Zacks Investment Research
<h3>Zacks Rank &amp; Key Picks</h3>
U.S. Steel currently carries a Zacks Rank #3 (Hold). 
Better-ranked stocks worth a look in the basic materials space include Denison Mines Corp. (AMEX:DNN), Carpenter Technology Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crs#NYSE">CRS</a>) and Innospec Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iosp#NASDAQ">IOSP</a>). 
Denison Mines beat the Zacks Consensus Estimate in each of the last four quarters, with the average earnings surprise being 300%. The company&#39;s shares have soared roughly 105% in the past year. DNN carries a Zacks Rank #1 (Strong Buy). 
The Zacks Consensus Estimate for Carpenter Technology&#39;s current fiscal year earnings is pegged at $3.96, indicating a year-over-year surge of 247.4%. CRS beat the Zacks Consensus Estimate in three of the last four quarters while matching it once, with the average earnings surprise being 12.2%. The company&#39;s shares have rallied around 68% in the past year. CRS currently carries a Zacks Rank #2 (Buy). 
The consensus estimate for Innospec&#39;s current-year earnings is pegged at $6.72 per share, indicating a 10.3% year-over-year rise. IOSP, carrying a Zacks Rank #2, beat the consensus estimate in each of the last four quarters, with the average earnings surprise being 10.5%. The company&#39;s shares have gained around 14% in the past year.
<a href="https://www.zacks.com/stock/news/2255178/u-s-steel-x-shareholders-clear-transaction-with-nippon-steel?cid=CS-BENZ-FT-analyst_blog|company_news_-_corporate_actions-2255178">To read this article on Zacks.com click here.</a>

U.S. Steel Shareholders Clear Transaction with Nippon Steel

Coeur Mining, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cde#NYSE">CDE</a>) announced that its newly expanded Rochester silver and gold mine in Nevada achieved commercial production. 
On Mar 7, the new three-stage crushing circuit and truck load-out facility were officially commissioned. Since then, the crusher circuit has operated at an average throughput of more than 70,000 tons per day and has topped 88,000 tons per day. This led to the declaration of commercial production by the end of the first quarter. 
Backed by this, the company additionally stated that the ramp-up to full planned capacity of 88,000 tons per day (about 32 million tons per year) is scheduled to be completed in the first half of 2024. With commissioning completed and ramp-up progressing well, the company will be able to shift its focus to mine optimization activities and business development programs aimed at maximizing the value of this world-class, long-life asset. 
Once fully operational, throughput levels are estimated to be 2.5 times higher than in the past, making Rochester one of the world&#39;s largest open-pit heap leach operations. It is expected to be America&#39;s largest source of domestically produced and processed silver, as well as a key driver of CDE&#39;s cash flow growth. 
In the fourth quarter of 2023, the company reported an adjusted loss of 2 cents per share, whereas the Zacks Consensus Estimate was pegged at breakeven. The company recorded revenues of $262 million in the quarter.
<h3>Price Performance</h3>
Coeur&#39;s shares have gained 15.3% in the past year compared with the industry&#39;s 34.7% growth.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/70/64608.jpg?v=842630886" /> 
Image Source: Zacks Investment Research
<h3>Zacks Rank &amp; Stocks to Consider</h3>
Coeur currently carries a Zacks Rank #3 (Hold). 
Some better-ranked stocks from the basic materials space are Ecolab Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ecl#NYSE">ECL</a>), Carpenter Technology Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crs#NYSE">CRS</a>) and Innospec Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iosp#NASDAQ">IOSP</a>). ECL and CRS sport a Zacks Rank #1 (Strong Buy) at present, and IOSP has a Zacks Rank #2 (Buy). 
The Zacks Consensus Estimate for Ecolab&#39;s 2024 earnings is pegged at $6.39 per share, indicating an increase of 22.7% from the prior year&#39;s reported number. It has an average trailing four-quarter earnings surprise of 1.7%. ECL shares have gained 41.8% in a year. 
The Zacks Consensus Estimate for Carpenter Technology&#39;s 2024 earnings is pegged at $4 per share. The consensus estimate for 2024 earnings has moved 1% north in the past 60 days. It has an average trailing four-quarter earnings surprise of 14.3%. CRS shares have gained 33.5% in a year. 
The Zacks Consensus Estimate for Innospec&#39;s 2024 earnings is pegged at $6.72 per share, indicating a year-over-year rise of 10.3%. The Zacks Consensus Estimate for IOSP&#39;s current-year earnings has been revised 2% north in the past 60 days. It has an average trailing four-quarter earnings surprise of 10.5%. The company&#39;s shares have rallied 19.3% in the past year.
<a href="https://www.zacks.com/stock/news/2252780/coeur-s-cde-rochester-mine-starts-commercial-operation?cid=CS-BENZ-FT-analyst_blog|company_news_-_corporate_actions-2252780">To read this article on Zacks.com click here.</a>

Penny Stocks

Coeur's (CDE) Rochester Mine Starts Commercial Operation

Innospec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOSP#NASDAQ">IOSP</a>) reported quarterly earnings of $1.84 per share which beat the analyst consensus estimate of $1.62 by 13.58 percent. This is a 53.33 percent increase over earnings of $1.20 per share from the same period last year. The company reported quarterly sales of $494.70 million which beat the analyst consensus estimate of $479.47 million by 3.18 percent. This is a 3.13 percent decrease over sales of $510.70 million the same period last year.

Innospec Q4 EPS $1.84 Beats $1.62 Estimate, Sales $494.70M Beat $479.47M Estimate

Innospec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOSP#NASDAQ">IOSP</a>) reported its Q4 earnings results on Tuesday, February 13, 2024 at 04:45 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Innospec beat estimated earnings by 13.58%, reporting an EPS of $1.84 versus an estimate of $1.62.
Revenue was down $16.00 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company beat on EPS by $0.14 which was followed by a 1.97% increase in the share price the next day.
Here's a look at Innospec's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.45</td>
<td>1.31</td>
<td>1.17</td>
<td>1.39</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.59</td>
<td>1.28</td>
<td>1.38</td>
<td>1.20</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>481.17M</td>
<td>498.47M</td>
<td>496.47M</td>
<td>485.73M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>464.10M</td>
<td>480.40M</td>
<td>509.60M</td>
<td>510.70M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Innospec <a href="https://www.benzinga.com/quote/IOSP/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Innospec: Q4 Earnings Insights

ABNB

AKAM

AKTS

ALSN

ANGI

ATOM

BENF

BFAM

BIIB

BRKR

CART

CHCT

CRSR

CTHR

DDOG

DENN

DNUT

ELMD

ENTG

FELE

GCMG

GDDY

GNSS

GORO

HOOD

HYLN

INCY

INMD

INVH

IPGP

KTOS

LCII

LDOS

LOPE

LYFT

MODG

NMTC

NTWK

QDEL

REZI

ROIV

RUSHA

RUSHB

SHOP

SITC

SITM

SMWB

SSNC

STAG

TYGO

UFCS

UPST

USAC

VTGN

Earnings Scheduled For February 13, 2024

Innospec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOSP#NASDAQ">IOSP</a>) is set to give its latest quarterly earnings report on Tuesday, 2024-02-13. Here's what investors need to know before the announcement.
Analysts estimate that Innospec will report an earnings per share (EPS) of $1.62. 
Innospec bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Historical Earnings Performance</h3>
Last quarter the company beat EPS by $0.14, which was followed by a 1.97% increase in the share price the next day.
Here's a look at Innospec's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.45</td>
<td>1.31</td>
<td>1.17</td>
<td>1.39</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.59</td>
<td>1.28</td>
<td>1.38</td>
<td>1.20</td>
</tr>
<tr>
<td>Price Change %</td>
<td>1.97%</td>
<td>3.09%</td>
<td>1.41%</td>
<td>-3.41%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1707750067_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Innospec were trading at $118.9 as of February 09. Over the last 52-week period, shares are up 5.0%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<a href="https://www.benzinga.com/quote/IOSP/earnings">To track all earnings releases for Innospec visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Outlook For Innospec

Founded in 1992, QGP has 300 employees. Innospec will integrate QGP into its Performance Chemicals business.

Innospec Completes Acquisition Of QGP Química Geral, A Specialty Chemicals Company Based In Brazil; Terms Not Disclosed

Innospec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOSP#NASDAQ">IOSP</a>) reported quarterly earnings of $1.59 per share which beat the analyst consensus estimate of $1.45 by 9.66 percent. This is a 8.62 percent decrease over earnings of $1.74 per share from the same period last year. The company reported quarterly sales of $464.10 million which missed the analyst consensus estimate of $481.17 million by 3.55 percent. This is a 9.53 percent decrease over sales of $513.00 million the same period last year.

Innospec Q3 Adj $1.59 Beats $1.45 Estimate, Sales $464.10M Miss $481.17M Estimate

Innospec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOSP#NASDAQ">IOSP</a>) reported quarterly Adj earnings of $1.28 per share which missed the analyst consensus estimate of $1.31 by 2.29 percent. This is a 18.99 percent decrease over earnings of $1.58 per share from the same period last year. The company reported quarterly sales of $480.40 million which missed the analyst consensus estimate of $498.47 million by 3.63 percent. This is a 2.74 percent increase over sales of $467.60 million the same period last year.

Innospec Q2 Adj EPS $1.28 Misses $1.31 Estimate, Sales $480.40M Miss $498.47M Estimate

AVNT

BCPC

CTVA

LTHM

MEOH

NGVT

TANH

TROX

Shares of chemical companies are trading higher amid overall market strength on renewed economic optimism following US Senate passage of a debt limit bill and strong US jobs data.

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Innospec (NASDAQ:<a href="https://investorplace.com/stock-quotes/iosp-stock-quote/">IOSP</a>) just reported results for the second quarter of 2024.<ul><li>Innospec reported earnings per share of $1.39. This was above the analyst estimate for EPS of $1.37.</li><li>The company reported revenue of $435.00 million.</li><li>This was 9.45% worse than the analyst estimate for revenue of $480.40 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/iosp-stock-earnings-innospec-for-q2-of-2024/">IOSP Stock Earnings: Innospec Beats EPS, Misses Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

IOSP Stock Earnings: Innospec Beats EPS, Misses Revenue for Q2 2024

In a report released today, Michael Harrison CFA from Seaport Global maintained a Hold rating on Innospec (IOSP – Research Report). The company's s...

Seaport Global Sticks to Their Hold Rating for Innospec (IOSP)

Innospec, Inc. (IOSP) Q2 2024 Earnings Call Transcript

The specialty chemical industry is growing steadily as chemical products are the base products for many industrial sectors. Hence, it could be wise to buy top specialty chemicals stocks, LyondellBasell Industries (LYB), Innospec (IOSP), and NewMarket Corp (NEU) for innovative materials. Read more... The global chemical industry is experiencing substantial growth, fueled by increased sustainability initiatives and rising demand across various sectors. Given the industry's tailwinds, investors could consider buying fundamentally sound chemicals stocks, LyondellBasell Industries N.V. (<a href="https://stocknews.com/stock/LYB/">LYB</a>), Innospec Inc. (<a href="https://stocknews.com/stock/IOSP/">IOSP</a>), and NewMarket Corporation (<a href="https://stocknews.com/stock/NEU/">NEU</a>).
Specialty chemicals are used across nearly every industrial sector. Over half of the global production is consumed by four key industries: food and beverages, soap, cleaning, and cosmetics, construction, and electronics. The global specialty chemicals market is anticipated to grow at a <a href="https://www.grandviewresearch.com/industry-analysis/specialty-chemicals-market">CAGR of 5.2% by 2030</a>, driven by industrialization and rising consumer economies.
Moreover, rising environmental concerns are pushing industries to adopt <a href="https://www.databridgemarketresearch.com/reports/global-chemicals-market">sustainable practices, from renewable resources to eco-friendly production</a> and recyclable chemical industry products. Companies embracing these changes meet regulations and cater to the growing demand for eco-conscious options.
Considering these encouraging trends, let's take a look at the fundamentals of the three best <a href="https://stocknews.com/category/chemicals/">Chemicals</a> industry stocks, beginning with the third choice. 
Stock #3: LyondellBasell Industries N.V. (<a href="https://stocknews.com/stock/LYB/">LYB</a>)
LYB is a chemical company operating internationally. It operates in six segments: Olefins and Polyolefins Americas; Olefins and Polyolefins Europe, Asia, International; Intermediates and Derivatives; Advanced Polymer Solutions; Refining; and Technology.
On May 30, 2024, LYB and Alujain Corporation announced the completion of LYB's acquisition of a 35% interest in Saudi Arabia–based National Petrochemical Industrial Company (NATPET) from Alujain.
The joint venture is enabled by LYB Spheripol polypropylene (PP) technology and positions LYB to profitably expand its core PP business by gaining access to advantaged feedstocks and additional product marketing volumes.
LYB's trailing-12-month ROCE of 17.57% is 185.3% higher than the 6.16% industry average. Its trailing-12-month ROTC of 7.67% is 55.8% higher than the 4.92% industry average. Likewise, the company's trailing-12-month ROTA of 6.26% is 154.9% higher than the 2.46% industry average.
For the second quarter ended June 30, 2024, LYB's sales and other <a href="https://www.investopedia.com/terms/o/operating-revenue.asp">operating revenues</a> increased 2.4% year-over-year to $10.56 billion. The company generated a net income of $924 million, up 29.2% year-over-year. Moreover, its EPS grew 95.8% year-over-year to $2.18.
For the fourth quarter ending December 31, 2024, EA's revenue is expected to increase marginally year-over-year to $10.69 billion. Its EPS for the same quarter is expected to grow 43.6% year-over-year to $1.81. Moreover, the company surpassed revenue estimates in each of the trailing four quarters, which is impressive.
LYB's stock has gained 2.8% over the month to close the last trading session at $96.20.
LYB's <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a> reflect this robust outlook. The stock has an overall rating of B, which translates to a Buy in our proprietary rating system. The POWR Ratings are calculated by considering 118 different factors, with each factor weighted to an optimal degree.
The stock has a B grade for Value and Stability. It is ranked #25 in the 80-stock B-rated <a href="https://stocknews.com/category/chemicals/">Chemicals</a> industry.
Beyond what is stated above, we've also rated LYB for Momentum, Growth, Sentiment, and Quality. Get all LYB ratings <a href="https://stocknews.com/stock/LYB/">here</a>.
Stock #2: Innospec Inc. (<a href="https://stocknews.com/stock/IOSP/">IOSP</a>)
IOSP develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, the rest of North America, the United Kingdom, the rest of Europe, and internationally. The company operates through three segments: Performance Chemicals, Fuel Specialties, and Oilfield Services.
On June 5, 2024, IOSP, a global leader in specialty chemicals, announced that its Performance Chemicals business had entered into a social partnership with the International Justice Mission (IJM).  
IJM is a global nonprofit organization working with local authorities in 33 communities to combat modern slavery and violence against women, rescuing and restoring victims, holding perpetrators accountable, and strengthening the local public justice systems to build a safe future that lasts.
IOSP's trailing-12-month gross profit margin of 30.65% is 8.1% higher than the 28.36% industry average. Its trailing-12-month net income margin of 7.90% is 57.4% higher than the 5.02% industry average. Likewise, the company's trailing-12-month levered FCF margin of 7.19% is 33.6% higher than the 5.38% industry average.
For the fiscal second quarter that ended June 30, 2024, IOSP's net sales were reported at $435 million. The company's gross profit was reported at $126.90 million. In addition, the company's net income stood at $31.20 million and earnings per share at $1.24, up 8% and 6.9% year-over-year.
Street expects IOSP's revenue for the fiscal third quarter (ending September 2024) to increase 6.7% year-over-year to $495.10 million. The company's EPS is expected to rise 4.4% from the prior year's quarter to $1.66. Moreover, the company surpassed EPS estimates in each of the trailing four quarters.
Over the past nine months, the stock has gained 10% to close the last trading session at $109.43.
IOSP's strong fundamentals are reflected in its POWR Ratings. It has an overall rating of B, which equates to a Buy in our proprietary rating system.
IOSP has a B grade for Stability and Sentiment. The stock is ranked #12 in the same industry.
<a href="https://stocknews.com/stock/IOSP/">Click here</a> to access the additional IOSP ratings (Growth, Momentum, Value, and Quality).
Stock #1: NewMarket Corporation (<a href="https://stocknews.com/stock/NEU/">NEU</a>)
NEU primarily manufactures and sells petroleum additives. The company offers lubricant additives for use in various vehicle and industrial applications, including engine oils, transmission fluids, off-road powertrains, and hydraulic systems.
On August 8, 2024, NEU declared a quarterly dividend in the amount of $2.50 per share, payable on October 1, 2024. The company pays $10 annually, which translates to a yield of 1.85% on the prevailing price level. Its four-year average dividend yield is 2.17%. The company has raised its dividend payouts at a CAGR of 7.7% over the past three years.
NEU's trailing-12-month gross profit margin of 29.94% is 5.6% higher than the 28.36% industry average. Its trailing-12-month EBIT margin of 20.68% is 92.4% higher than the 10.75% industry average. Likewise, the company's trailing-12-month EBITDA margin of 24.09% is 46.9% higher than the 16.40% industry average.
During the second quarter, which ended June 30, 2024, NEU reported net sales of $710.23 million, up 3.7% year-over-year. Its segment operating profit increased 15.5% from the previous year's quarter to $151.42 million. The company's net income and EPS were $111.62 million and $11.63, up 12% and 12.3% year-over-year, respectively.
Shares of NEU have soared 7.3% over the past month to close the last trading session at $546.20.
NEU's POWR Ratings reflect bright prospects. The stock has an overall rating of A, which equates to a Strong Buy in our proprietary rating system.
NEU has a B grade for Growth, Stability, Sentiment, and Quality. It is ranked #5 in the same industry.
In addition to the POWR Ratings highlighted above, one can access NEU's ratings for Momentum and Value <a href="https://stocknews.com/stock/NEU/">here</a>.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>

<hr />
LYB shares were trading at $96.84 per share on Friday afternoon, up $0.64 (+0.67%). Year-to-date, LYB has gained 4.55%, versus a 12.81% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Nidhi Agarwal</h2> <img src='https:/wp-content/uploads/2023/03/Nidhi-Agarwal_Headshot-3.jpg' style="float:left; padding:5px;width:125px;">Nidhi is passionate about the capital market and wealth management, which led her to pursue a career as an investment analyst. She holds a bachelor's degree in finance and marketing and is pursuing the CFA program.

Her fundamental approach to analyzing stocks helps investors identify the best investment opportunities.<a href="https://stocknews.com/authors/?author=nidhi-agarwal">More...</a>The post <a href=https://stocknews.com/news/lyb-neu-iosp-3-specialty-chemical-stocks-for-innovative-materials/>3 Specialty Chemical Stocks for Innovative Materials</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 Specialty Chemical Stocks for Innovative Materials

Innospec Navigating Turbulent End-Markets And Specialty Chemical De-Rating Relatively Well

Warning: IOSP is at high risk of performing badly

Innospec Non-GAAP EPS of $1.35 in-line, revenue of $443.4M beats by $1.27M

Reports Q3 revenue $443.4M, consensus $442.13M. Commenting on the third quarter results, Patrick S. Williams, President and Chief Executive Officer...

Innospec reports Q3 adjusted EPS $1.35, consensus $1.35

Innospec raises dividend by 3.9%

CLZNF

CLZNY

DSFIY

DSMFF

EVKIF

EVKIY

LZAGF

LZAGY

Press Releases

Innospec Reports Fourth Quarter and Full Year 2023 Financial Results

Innospec Schedules First Quarter 2024 Earnings Release and Conference Call

Innospec Reports First Quarter 2024 Financial Results

Innospec and IJM Announce New Partnership to Strengthen Protection for Palm Oil Workers in Southeast Asia

General

Innospec Achieves Gold Rating in EcoVadis Sustainability Assessment for the Fourth Consecutive Time

Comments

Innospec

Innospec (IOSP) Opzioni

Innospec (NASDAQ:IOSP) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO